Ferritin nanoparticles as magnetic resonance reporter gene

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 1, Issue 2, 2009, Pages 181-188

  Cohen, Batya ^a   Ziv, Keren ^a   Plaks, Vicki ^a   Harmelin, Alon ^a   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MECHANISM; DYNAMIC IMAGING; FLUORESCENCE OPTICAL IMAGING; GREEN FLUORESCENT PROTEIN; HIGH SPATIAL RESOLUTION; IRON-BINDING PROTEIN; PROMOTER REGION; REGULATORY ELEMENTS;

BIOLUMINESCENCE; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; TISSUE;

GENE EXPRESSION;

DIAGNOSTIC AGENT; FERRITIN; NANOPARTICLE;

ANIMAL; GENE EXPRESSION PROFILING; GENETIC PROCEDURES; GENETICS; HUMAN; IMAGE ENHANCEMENT; IRON METABOLISM DISORDER; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REPORTER GENE; REVIEW; ULTRASTRUCTURE;

ANIMALS; FERRITINS; GENE EXPRESSION PROFILING; GENES, REPORTER; HUMANS; IMAGE ENHANCEMENT; IRON METABOLISM DISORDERS; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBE TECHNIQUES; NANOPARTICLES;

EID: 77949317418     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.11     Document Type: Review

References (80)

1. Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev 1995, 53(9):237-245.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999, 341(26):1986-1995.
3. Provan D. Mechanisms and management of iron deficiency anaemia. Br J Haematol 1999, 105(suppl 1):19-26.
4. El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000, 132(4):261-269.
5. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J MedGenet 1997, 34(4):275-278.
6. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, Mcquillan GM, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001, 285(17):2216-2222.
7. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarker NMR Biomed 2004, 17(7):433-445.
8. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006, 28(5):311-315.
9. BartzokisG, BecksonM, HanceDB, MarxP, Foster JA, et al. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 1997, 15(1):29-35.
10. Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci 2004, 1012:224-236.
11. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, et al. Brain ferritin iron may influence ageand gender-related risks of neurodegeneration. Neurobiol Aging 2007, 28(3):414-423.
12. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, et al.MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999, 17(2):213-222.
13. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-le-grand) 2000, 46(4):821-833.
14. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, et al. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol 2007, 62(1):138-142.
15. Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2006, 2(8):406-414.
16. Aziz N, Munro HN. Both subunits of rat liver ferritin are regulated at a translational level by iron induction. Nucleic Acids Res 1986, 14(2):915-927.
17. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002, 33(4):457-463.
18. Cazzola M, Foglieni B, Bergamaschi G, Levi S, Lazzarino M, et al. A novel deletion of the L-ferritin ironresponsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome. Br J Haematol 2002, 116(3):667-670.
19. Galy B, Ferring D, Minana B, Bell O, Janser HG, et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 2005, 106(7):2580-2589.
20. Lavaute T, Smith S, Cooperman S, Iwai K, Land W, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001, 27(2):209-214.
21. Smith SR, Ghosh MC, Ollivierre-Wilson H, Hang Tong W, Rouault TA. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development. Blood Cells Mol Dis 2006, 36(2):283-287.
22. Galy B, Ferring D, Benesova M, Benes V, Hentze MW. Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo. RNA 2004, 10(7):1019-1025.
23. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 2004, 23(2):386-395.
24. Ferreira C, Santambrogio P, Martin ME, Andrieu V, Feldmann G, et al. H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload. Blood 2001, 98(3):525-532.
25. Ferreira C, Bucchini D, Martin ME, Levi S, Arosio P, et al. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem 2000, 275(5):3021-3024.
26. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, et al.Mouse brains deficient inH-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 2003, 71(1):46-63.
27. Ill AM, Mitchell TR, Neely EB, Connor JR. Metabolic analysis of mouse brains that have compromised iron storage. Metab Brain Dis 2006, 21(2-3):77-87.
28. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119(4):529-542.
29. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 2003, 37(6):899-909.
30. McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, et al. Role of oxidative stress in paraquatinduced dopaminergic cell degeneration. J Neurochem 2005, 93(4):1030-1037.
31. Kaur D, Rajagopalan S, Chinta S, Kumar J, DiMonte D, et al. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res 2007, 1140:188-194.
32. Wilkinson J, Di X, Schonig K, Buss JL, Kock ND, et al. Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo. Biochem J 2006, 395(3):501-507.
33. Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 2007, 13(4):498-503.
34. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275(3):161-203.
35. Douglas T, Ripoll DR. Calculated electrostatic gradients in recombinant human H-chain ferritin. Protein Sci 1998, 7(5):1083-1091.
36. Takahashi T, Kuyucak S. Functional properties of threefold and fourfold channels in ferritin deduced from electrostatic calculations. Biophys J 2003, 84(4):2256-2263.
37. Treffry A, Zhao Z,Quail MA, Guest JR,Harrison PM. Dinuclear center of ferritin: studies of iron binding and oxidation show differences in the two iron sites. Biochemistry 1997, 36(2):432-441.
38. Levi S, Luzzago A, Cesareni G, Cozzi A, Franceschinelli F, et al. Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferro-oxidase site. A study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. J Biol Chem 1988, 263(34:):18086-18092.
39. Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, et al. Identification of the ferroxidase centre in ferritin. FEBS Lett 1989, 254(1-2):207-210.
40. Bou-Abdallah F, Biasiotto G, Arosio P, Chasteen ND. The putative "nucleation site" in human H-chain ferritin is not required for mineralization of the iron core. Biochemistry 2004, 43(14):4332-4337.
41. Levi S, Yewdall SJ, Harrison PM, Santambrogio P, Cozzi A, et al. Evidence of H- and L-chains have cooperative roles in the iron-uptake mechanism of human ferritin. Biochem J 1992, 288(Pt 2):591-596.
42. Zhao G, Bou-Abdallah F, Arosio P, Levi S, Janus-Chandler C, et al. Multiple pathways for mineral core formation inmammalian apoferritin. The role of hydrogen peroxide. Biochemistry 2003, 42(10):3142-3150.
43. Frankel RB, Papaefthymiou GC, Watt GD. Variation of superparamagnetic properties with iron loading in mammalian ferritin. Hyperfine Interact 1991, 66(1-4):71-82.
44. Bauminger ER, Treffry A, Hudson AJ, Hechel D, Hodson NW, et al. Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli. Biochem J 1994, 302(Pt 3):813-820.
45. Bauminger ER, Harrison PM, Hechel D, Nowik I, Treffry A. Iron (III) can be transferred between ferritin molecules. Proc Biol Sci 1991, 244(1311):211-217.
46. Ofer S, Fibach E, Kessel M, Bauminger ER, Cohen SG, et al. Iron incorporation into ferritin and hemoglobin during differentiation of murine erythroleukemia cells. Blood 1981, 58(2):255-262.
47. Weir MP, Sharp GA, Peters TJ. Electron microscopic studies of human haemosiderin and ferritin. J Clin Pathol 1985, 38(8):915-918.
48. Koorts AM, Viljoen M. Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. Arch Physiol Biochem 2007, 113(2):55-64.
49. Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 2007, 113(1):30-54.
50. Miyazaki E, Kato J, Kobune M, Okumura K, Sasaki K, et al. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut 2002, 50(3):413-419.
51. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005, 23(1):1-25.
52. Gottesfeld Z, Neeman M. Ferritin effect on the transverse relaxation of water: NMR microscopy at 9.4 T. Magn Reson Med 1996, 35(4):514-520.
53. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA. T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 1996, 36(1):61-65.
54. Vymazal J, Brooks RA, Bulte JW, Gordon D, Aisen P. Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem 1998, 71(3-4):153-157.
55. Aime S, Frullano L, Geninatticrich S. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed Engl 2002, 41(6):1017-1019.
56. Collawn JF, Fish WW Jr: Hydrogen-tritium exchange by apoferritin and ferritin. Arch Biochem Biophys 1985, 240(1):242-245.
57. Gossuin Y, Roch A, Muller RN, Gillis P, Lo Bue F. Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med 2002, 48(6):959-964.
58. Wood JC, Fassler JD, Meade T. Mimicking liver iron overload using liposomal ferritin preparations. Magn Reson Med 2004, 51(3):607-611.
59. Vymazal J, Brooks RA, Zak O, McRill C, Shen C, et al. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992, 27(2):368-374.
60. Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 1993, 29(4):459-464.
61. Storey P, Thompson AA, Carqueville CL,Wood JC, de Freitas RA, et al. R2 imaging of transfusional iron burden at 3T and comparison with 1.5 T. J Magn Reson Imaging 2007, 25(3):540-547.
62. Gossuin Y, Gillis P, Muller RN, Hocq A. Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo. NMR Biomed 2007, 20:749-756.
63. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005, 7(2):109-117.
64. Genove G, Demarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 2005, 11(4):450-454.
65. Negrin RS, Contag CH. In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev Immunol 2006, 6(6):484-490.
66. Doyle TC, Burns SM, Contag CH. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol 2004, 6(4):303-317.
67. Zhang J, Campbell RE, Ting AY, Tsien RY. Creating new fluorescent probes for cell biology. Nat Rev Immunol 2002, 3(12):906-918.
68. Ray P, Bauer E, Iyer M, Barrio JR, Satyamurthy N, et al.Monitoring gene therapy with reporter gene imaging. Semin Nucl Med 2001, 31(4):312-320.
69. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 2004, 64(4):1323-1330.
70. Gilad AA, McMahon MT,Walczak P,Winnard PT, Jr., Raman V, et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007, 25(2):217-219.
71. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000, 18(3):321-325.
72. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS, et al. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 1997, 204(2):425-429.
73. Koretsky AP, Lin YJ, Schorle H, Jaenisch R. Genetic control ofMRI contrast by expression of the transferrin receptor. Fourth Meeting of the International Society for Magnetic Resonance in Medicine, New York, Vol. 1, 1996, 69.
74. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1998, 1402(3):239-249.
75. Moore A, Josephson L, Bhorade RM, Basilion JP, Weissleder R. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001, 221(1):244-250.
76. Hogemann D, Josephson L, Weissleder R, Basilion JP. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 2000, 11(6):941-946.
77. Deans AE, Wadghiri YZ, Bernas LM, Yu X, Rutt BK, et al. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med 2006, 56(1):51-59.
78. Grabill C, Silva AC, Smith SS, Koretsky AP, Rouault TA. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res 2003, 971(1):95-106.
79. Bennett KM, Shapiro EM, Sotak CH, Koretsky AP. Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys J 2008, 95(1):342-351.
80. Stritzker J, Hill PJ, Scadeng M, Szalay AA. In vivo evaluation of an inducible MRI reporter gene. Proc Int Soc Magn Reson Med 2007, 15:860.